Evidence map›Paper›PMID 30795562›Full record

ArticleCancers2019

Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery.

Alfons Navarro, Laureano Molins, Ramon M Marrades, Jorge Moises, Nuria Viñolas, Sara Morales, Jordi Canals, Joan J Castellano, José Ramírez, Mariano Monzo

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. The therapeutic potential of exosomes in lung cancer.Cellular oncology (Dordrecht, Netherlands) · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. The Emerging Role of Exosomes in Cancer Chemoresistance.Frontiers in cell and developmental biology · 2021
    Review
  18. Article
  19. [Advances in Exosomes in the Pathogenesis and Diagnosis of Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Alfons NavarroMolecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain. anavarroponz@ub.edu.ORCID 0000-0001-6071-0926
Laureano MolinsDepartment of Thoracic Surgery, Institut Clínic de Respiratori (ICR), Hospital Clínic de Barcelona, University of Barcelona, 08036 Barcelona, Spain. lmolins@clinic.cat.ORCID 0000-0001-6978-2715
Ramon M MarradesDepartment of Pneumology, Institut Clínic de Respiratori (ICR), Hospital Clínic de Barcelona, University of Barcelona, IDIBAPS, CIBER de Enfermedades Respiratorias (CIBERES), 08036 Barcelona, Spain. marrades@clinic.cat.
Jorge MoisesDepartment of Pneumology, Institut Clínic de Respiratori (ICR), Hospital Clínic de Barcelona, University of Barcelona, IDIBAPS, CIBER de Enfermedades Respiratorias (CIBERES), 08036 Barcelona, Spain. jrmoises@clinic.cat.ORCID 0000-0001-9504-7511
Nuria ViñolasDepartment of Medical Oncology, Institut Clínic Malalties Hemato-Oncològiques (ICMHO), Hospital Clínic de Barcelona, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain. nvinolas@clinic.cat.
Sara MoralesMolecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain. saramolo.19@gmail.com.ORCID 0000-0003-4396-2544
Jordi CanalsMolecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain. canals.serrat@ub.edu.
Joan J CastellanoMolecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain. joan.castellano@ub.edu.
José RamírezDepartment of Pathology, Centro de Diagnóstico Biomédico (CDB), Hospital Clínic de Barcelona, University of Barcelona, IDIBAPS, CIBERES, 08036 Barcelona, Spain. jramirez@clinic.cat.
Mariano MonzoMolecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, 08036 Barcelona, Spain. mmonzo@ub.edu.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital Clínic de Barcelona · ES

Funding

Fundación Científica Asociación Española Contra el Cáncer AECC-Catalunya 2017Ministerio de Economía y Competitividad SAF2017-88606-P
6 · The paper itself

Abstract

Since tumor-draining pulmonary vein blood (PV) is enriched in tumor-secreted products, we hypothesized that it would also be enriched in tumor-derived exosomes, which would be important in the metastasis process. We characterized exosomes from PV of 61 resected non-small cell lung cancer (NSCLC) patients to evaluate its potential as relapse biomarkers. Exosomes were characterized using transmission electron microscopy, western blot and nanoparticle tracking analysis and we examined time to relapse (TTR) and overall survival (OS). Differences between PV and peripheral vein were found. PV was enriched in smaller exosomes than the paired peripheral vein (

Indexed as

exosomeextracellular vesicleslung cancerNSCLCrelapsetumor-draining vein

Identifiers

PMID30795562
PMCPMC6407158
OpenAlexW2918045954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.